Browsing Tag
desmoid tumors
3 posts
Why Immunome’s Phase 3 varegacestat data could reshape the desmoid tumor treatment market
Immunome is set to release Phase 3 varegacestat data that could redefine its oncology strategy and valuation. Read what this catalyst really means.
Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal
Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company…
Ayala Pharmaceuticals AL102 gets FDA fast track status in desmoid tumors
Ayala Pharmaceuticals has been granted fast track designation for its oral gamma-secretase inhibitor AL102 by the US Food…